Company Pulls HIV Drugs From WHO Program
615596
The Indian drug company Ranbaxy Laboratories, Ltd., has pulled all of its antiretroviral drugs from a World Health Organization (WHO) program that sets minimum quality standards for cheaper anti-AIDS drugs designated for use in poor nations.
211992
Doctors and AIDS activists in Africa are worried governments may halt use of an AIDS drug that has protected thousands of babies from HIV infection in reaction to new concerns about the drug's testing and effect on pregnant women.
737400
New Delhi: India&#39;s top drugmaker Ranbaxy Laboratories has voluntarily withdrawn all its antiretroviral AIDS drugs from the UN health agency&#39;s approved list, setting minimum quality standards for cheaper anti-AIDS medication aimed at poor countries, the
494319
Two generic AIDS treatments by Indian manufacturer Cipla have been reinstated on the World Health Organisation&#39;s recommended list, six months after they were removed for further testing.
733216
Clinical trials of an anti-virus gel supposed to help protect women against AIDS have been stopped after it was found that those on the treatment were more susceptible to HIV infection, the World Health Organisation said.
244841
The U.S. has halted payments to clinics that treat AIDS patients in Puerto Rico, forcing hundreds of poor people to go without free medicine in a U.S. territory with an AIDS rate nearly double that of the mainland.
177254
FOLLOWING Ranbaxy Laboratories&#39; decision to withdraw all its anti-retroviral (ARV) drugs from the World Health Organisation (WHO) list, the Health Ministry is concerned about this development and is likely to ask the Drugs Controller General of India (DCGI
277937
Thailand's top pharmaceutical group slammed the government's decision to allow generic versions of AIDS and heart drugs, saying it damaged the nation's image in the global business community.
452895
Cape Town - An Indian pharmaceutical company has withdrawn 10 of its generic Aids drugs citing flaws in the research, the Science and Development Network reports.
377355
Roche Pharmaceuticals announced a global recall of its HIV/AIDS drug Viracept after discovering that some batches had been contaminated with a carcinogen.
90172
Merck Labs has pulled Vioxx, their arthritis drug, off the market after discovering during trials the possibility of a link to stroke or heart attack.
745053
The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles as an Indian company withdrew its medicines last week because it can&#39;t guarantee they are potent enough.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
188597
A major maker of generic AIDS medicines voluntarily removed all its antiretroviral medications from the World Health Organization&#39;s list of approved drugs yesterday, a move that could potentially
224687
Hetero Drugs has withdrawn all six of its antiretroviral drugs from the WHO&#39;s list of approved drugs following concerns about their laboratory tests, the World Health Organization (WHO) said Friday.
733464
India's top pharmaceutical group Ranbaxy has withdrawn all its anti-AIDS drugs from World Health Organisation certification after it found the laboratory tests proving their effectiveness were deficient, the UN health agency said.
125028
Drug company Merck has removed its painkiller Vioxx because of data showing an increased risk of heart attack and stroke.